BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Bruno Christian Koehler, Toni Urbanik, Binje Vick, Regina Johanna Boger, Steffen Heeger, Peter R Galle, Marcus Schuchmann, Henning Schulze-Bergkamen. TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapiesWorld Journal of Gastroenterology 2009; 15(47): 5924-5935 doi: 10.3748/wjg.15.5924
Seon Min Woo, Kyoung-jin Min, Bo Ram Seo, Taeg Kyu Kwon. YM155 sensitizes TRAIL-induced apoptosis through cathepsin S-dependent down-regulation of Mcl-1 and NF-κB-mediated down-regulation of c-FLIP expression in human renal carcinoma Caki cellsOncotarget 2016; 7(38): 61520 doi: 10.18632/oncotarget.11137
D Schmid, G E Jarvis, F Fay, D M Small, M K Greene, J Majkut, S Spence, K M McLaughlin, K D McCloskey, P G Johnston, A Kissenpfennig, D B Longley, C J Scott. Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicityCell Death & Disease 2014; 5(10): e1454 doi: 10.1038/cddis.2014.413
G Polier, J Ding, B V Konkimalla, D Eick, N Ribeiro, R Köhler, M Giaisi, T Efferth, L Desaubry, P H Krammer, M Li-Weber. Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1Cell Death & Disease 2011; 2(7): e182 doi: 10.1038/cddis.2011.66
Haeng-Eun Lee, Jeong-Seok Nam, Ji-Ae Shin, In-Sun Hong, In-Hyoung Yang, Myung-Jo You, Sung-Dae Cho. Convallaria keiskei as a novel therapeutic alternative for salivary gland cancer treatment by targeting myeloid cell leukemia-1Head & Neck 2016; 38(S1): E761 doi: 10.1002/hed.24096
Soyoung Choi, Zhengming Chen, Laura H. Tang, Yuanzhang Fang, Sandra J. Shin, Nicole C. Panarelli, Yao-Tseng Chen, Yi Li, Xuejun Jiang, Yi-Chieh Nancy Du. Bcl-xL promotes metastasis independent of its anti-apoptotic activityNature Communications 2016; 7(1) doi: 10.1038/ncomms10384
Bodvael Pennarun, Jan H Kleibeuker, Wytske Boersma- van Ek, Frank AE Kruyt, Harry Hollema, Elisabeth GE de Vries, Steven de Jong. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAILThe Journal of Pathology 2013; 229(3): 410 doi: 10.1002/path.4138
Alena Vaculová, Jiřina Hofmanová, Jiřina Zatloukalová, Alois Kozubík. Differences in TRAIL-induced changes of Mcl-1 expression among distinct human colon epithelial cell linesExperimental Cell Research 2009; 315(19): 3259 doi: 10.1016/j.yexcr.2009.09.019
Xiang Guoan, Wang Hanning, Chen Kaiyun, Liu Hao. Adenovirus-mediated siRNA targeting Mcl-1 gene increases radiosensitivity of pancreatic carcinoma cells in vitro and in vivoSurgery 2010; 147(4): 553 doi: 10.1016/j.surg.2009.10.033
Amirmohammad Nasiri Kenari, Kenneth Kastaniegaard, David W. Greening, Mitch Shambrook, Allan Stensballe, Lesley Cheng, Andrew F. Hill. Proteomic and Post‐Translational Modification Profiling of Exosome‐Mimetic Nanovesicles Compared to ExosomesPROTEOMICS 2019; 19(8): 1800161 doi: 10.1002/pmic.201800161
Ulrich-Axel Bommer, Kara L. Vine, Prianka Puri, Martin Engel, Lisa Belfiore, Karen Fildes, Marijka Batterham, Alistair Lochhead, Morteza Aghmesheh. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatinCell Communication and Signaling 2017; 15(1) doi: 10.1186/s12964-017-0164-3
T Trarbach, M Moehler, V Heinemann, C-H Köhne, M Przyborek, C Schulz, V Sneller, G Gallant, S Kanzler. Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancerBritish Journal of Cancer 2010; 102(3): 506 doi: 10.1038/sj.bjc.6605507
Bruno Christian Koehler, Anna-Lena Scherr, Stephan Lorenz, Toni Urbanik, Nicole Kautz, Christin Elssner, Stefan Welte, Justo Lorenzo Bermejo, Dirk Jäger, Henning Schulze-Bergkamen, Jun Li. Beyond Cell Death – Antiapoptotic Bcl-2 Proteins Regulate Migration and Invasion of Colorectal Cancer Cells In VitroPLoS ONE 2013; 8(10): e76446 doi: 10.1371/journal.pone.0076446
Zineb El Fajoui, Florent Toscano, Guillaume Jacquemin, Jacques Abello, Jean–Yves Scoazec, Olivier Micheau, Jean–Christophe Saurin. Oxaliplatin Sensitizes Human Colon Cancer Cells to TRAIL Through JNK-Dependent Phosphorylation of Bcl-xLGastroenterology 2011; 141(2): 663 doi: 10.1053/j.gastro.2011.04.055
Janica C. Wong, Madhavi Bathina, Ronald R. Fiscus. Cyclic GMP/protein kinase G type‐Iα (PKG‐Iα) signaling pathway promotes CREB phosphorylation and maintains higher c‐IAP1, livin, survivin, and Mcl‐1 expression and the inhibition of PKG‐Iα kinase activity synergizes with cisplatin in non‐small cell lung cancer cellsJournal of Cellular Biochemistry 2012; 113(11): 3587 doi: 10.1002/jcb.24237
Bruno Christian Koehler, Anna-Lena Scherr, Stephan Lorenz, Christin Elssner, Nicole Kautz, Stefan Welte, Dirk Jaeger, Toni Urbanik, Henning Schulze-Bergkamen, Andrei L. Gartel. Pan-Bcl-2 Inhibitor Obatoclax Delays Cell Cycle Progression and Blocks Migration of Colorectal Cancer CellsPLoS ONE 2014; 9(9): e106571 doi: 10.1371/journal.pone.0106571
E P Booy, E S Henson, S B Gibson. Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancerOncogene 2011; 30(20): 2367 doi: 10.1038/onc.2010.616
Diego Y. Grinman, Leonardo Romorini, Diego M. Presman, Luciana Rocha-Viegas, Omar A. Coso, Carlos Davio, Adali Pecci. Role of 3′-5′-cyclic adenosine monophosphate on the epidermal growth factor dependent survival in mammary epithelial cellsMolecular and Cellular Endocrinology 2016; 419: 259 doi: 10.1016/j.mce.2015.10.026
Anthony W. Tolcher, Patricia LoRusso, Jennifer Arzt, Todd A. Busman, Guinan Lian, Niki S. Rudersdorf, Carol Ann Vanderwal, Jeffrey F. Waring, Jianning Yang, Kyle D. Holen, Lee S. Rosen. Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with irinotecan: results of an open-label, phase 1 studyCancer Chemotherapy and Pharmacology 2015; 76(5): 1041 doi: 10.1007/s00280-015-2882-9
Jorn Markus Schattenberg, Marcus Schuchmann, Peter Robert Galle. Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathwaysJournal of Gastroenterology and Hepatology 2011; 26: 213 doi: 10.1111/j.1440-1746.2010.06582.x
Wang Likui, Liu Qun, Zhou Wanqing, Shao Haifeng, Li Fangqiu, Li Xiaojun. Prognostic role of myeloid cell leukemia-1 protein (Mcl-1) expression in human gastric cancerJournal of Surgical Oncology 2009; 100(5): 396 doi: 10.1002/jso.21344
Ting Zhang, Chun Zhao, Liang Luo, Hua Zhao, Jing Cheng, Fei Xu. The expression of Mcl-1 in human cervical cancer and its clinical significanceMedical Oncology 2012; 29(3): 1985 doi: 10.1007/s12032-011-0005-y
B. N. Polite, B. E. Sylvester, O. I. Olopade. Race and Subset Analyses in Clinical Trials: Time to Get Serious About Data IntegrationJNCI Journal of the National Cancer Institute 2011; 103(20): 1486 doi: 10.1093/jnci/djr382
Chi-Hung Or, Yachu Chang, Wei-Cheng Lin, Wee-Chyan Lee, Hong-Lin Su, Muk-Wing Cheung, Chang-Po Huang, Cheesang Ho, Chia-Che Chang. Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma CellsInternational Journal of Molecular Sciences 2016; 18(1): 44 doi: 10.3390/ijms18010044
Estrella Mariel Levy, Gabriela Sycz, Juan Martin Arriaga, María Marcela Barrio, Erika María von Euw, Sergio Bayo Morales, Mariana González, José Mordoh, Michele Bianchini. Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cellsInnate Immunity 2009; 15(2): 91 doi: 10.1177/1753425908101404